Figure 4From: Metallopanstimulin as a marker for head and neck cancerPatient without evidence of disease from surgery through radiation therapy (draws 1–5). The patient suffered a recurrence of clinical disease following radiation therapy (draws 6–8), which progressed until death.Back to article page